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Abstract
The mechanism of the inhibitory effect of imipramine, a lipophilic organic cation on the Naq-dependent transport of
L-glutamic acid across intestinal brush-border membrane was investigated. The uptake of L-glutamic acid by intestinal
brush-border membrane vesicles was dependent on the concentration of Naq. Fitting of the uptake data in the presence of
various concentrations of Naq using Hill equation yielded a Hill coefficient of 2.18. This result suggest that the carrier
system of L-glutamic acid has at least two sites for Naq-binding. By the analysis of double reciprocal plot and Dixon-type
plot, it was found that imipramine inhibits the transport of L-glutamic acid by interacting competitively with the binding
sites of Naq, but not inhibit L-glutamic acid binding site. Moreover, the effect of imipramine on the transport of L-alanine
and D-glucose which are co-transported with only one Naq molecule was also suggestive of interaction with the
Naq-binding sites on the carrier. These results indicate that the mechanism of the inhibitory effect of imipramine on the
Naq-dependent carrier systems is common for all systems regardless of the stoichiometry or substrates. q 1998 Elsevier
Science B.V.
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1. Introduction
Naq-dependent carrier-mediated transport systems
exist widely in various organs, and play an important
role in the disposition of nutrients and sometimes
drugs. It was reported that these Naq-dependent car-
rier-mediated transport systems can be inhibited by
w xvarious lipophilic organic cations 1–4 . A typical
compound is harmaline which inhibits the transport
of sugar and neutral amino acid by interacting com-
petitively with the Naq-binding site on the carrier
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w xprotein 1,3,4 . Imipramine, a tricyclic antidepressant,
also inhibits the Naq-dependent transporters of sugar
w xand serotonin by a similar mechanism 1,2,5,6 . How-
ever, in the literature there are some discrepancies in
interpreting the manner of inhibition with respect to
the competition between substrate and these cationic
Fig. 1. Chemical formula of imipramine.
0005-2736r98r$19.00 q 1998 Elsevier Science B.V. All rights reserved.
 .PII S0005-2736 97 00270-8
( )M. Sugawara et al.rBiochimica et Biophysica Acta 1370 1998 252–258 253
w xinhibitors. Young et al. 4 reported that harmaline
non-competitively inhibits the transport of alanine
mediated by amino acid transport system ASC in the
human erythrocytes. It was also reported that the
w xuptake of serotonin by human and rat platelets 6 and
w xrat enterocytes 2 can be inhibited by imipramine
with a non-competitive manner. On the other hand, a
competitive-type of inhibition was reported for the
inhibitory effect of harmaline and imipramine on the
uptake of methyl a-D-glucose by everted rings of rat
w xsmall intestine 1 and for the effect of imipramine on
the uptake of serotonin by human platelet. Further-
more, the analysis of inhibition manner of organic
cation was carried out only for transporters with a
transport stoichiometry of substrate and Naq of 1:1,
and there is no information on co-transporters with
more than two Naq.
In the present study, we investigate the effect of
 .imipramine Fig. 1 on the uptake of L-glutamic acid,
which is transported with two Naq molecule, by rat
intestinal brush-border membrane vesicles in order to
clarify the type of inhibitory effect with respect to the
competition on the substrate binding site and the
Naq-binding sites. Moreover, we examine the effect
of imipramine on the uptake of L-alanine and D-glu-
cose to compare the type of inhibition of these trans-
porters.
2. Materials and methods
2.1. Chemicals
w 3 x  . wL- 2,3- H Alanine 2.00 TBqrmmol , D- U-
14 x  . wC glucose 10.8 GBqrmmol , and L- G-
3 x  .H glutamic acid 2.07 TBqrmmol were obtained
from Amersham International. D-Glucose and L-
glutamic acid were purchased from Wako Pure
 .Chemical Industries Osaka, Japan . Alanine and
Imipramine hydrochloride were obtained from Nacalai
 . Tesque Kyoto, Japan and Sigma Chemical St.
.Louis, MO, USA , respectively. All other chemicals
were of the highest grade available.
2.2. Preparation of intestinal brush-border mem-
brane ˝esicles
 .Male Wistar rats 200–250 g were used for the
isolation of membrane vesicles and all the procedures
were carried out at 48C or ice-cold conditions. The
small intestinal brush-border membrane vesicles were
prepared according to Mg2qrEGTA precipitation
w xmethods 7,8 with some modifications. The scraped
intestinal mucosa was homogenized with a Warring
 .blender Nihon Seiki, Japan at 16 000 rpm for 4 min
 .in an appropriate volume 40 mlrrat of a homoge-
nizing buffer composed of 50 mM D-Mannitol, 2.5
mM EGTA, and 2 mM Tris pH 7.1 adjusted by
.addition of NaOH . Then, MgCl was added to a2
final concentration of 10 mM. After 20 min, the
mixture was centrifuged at 3000=g for 15 min. The
supernatant was then centrifuged at 17 000=g for 30
min. Then the pellet was suspended and homogenized
 .by a Dounce-type homogenizer 10 strokes in 40 ml
of the same homogenizing buffer. MgCl was added2
again to a final concentration of 10 mM and the first
two steps of centrifugation were repeated once more.
The resulting pellet was washed with an experimental
buffer composed of 100 mM D-Mannitol, 100 mM
 .KCl, and 20 mM HepesrTris pH 7.5 by homoge-
nizing in 40 ml of the experimental buffer using
Dounce-type homogenizer and centrifugation at
27 000=g for 30 min. The final pellet was resus-
pended in the experimental buffer using a Dounce-
type homogenizer to give a final protein concentra-
tion of 10–15 mgrml. Enrichment of the brush-border
membrane fraction was 9–11-fold compared to the
initial homogenate from assessment of the specific
activity of the membrane enzyme marker, alkaline
phosphatase.
2.3. Uptake experiments
The uptake of substrates into membrane vesicles
 . was performed at 258C D-glucose or 378C L-alanine
.and L-glutamic acid by a rapid filtration technique
w xaccording to our previous reports 9,10 with minor
modification. Briefly, the reaction was initiated by
mixing of 20 ml of membrane vesicle suspension
with 100 ml of the transport buffer 20 mM
 .HepesrTris pH 7.5 , 100 mM D-mannitol, and suit-
able concentrations of KCl and NaCl indicated in
..figure legend containing 12 KBqrml of labeled and
suitable concentrations of non-labeled substrate to
.adjust substrate concentration with or without vari-
ous concentrations of imipramine. Then at the stated
time, the reaction was terminated by diluting the
reaction mixture with 4 ml of the ice-cold stop buffer
 .150 mM NaCl, 20 mM HepesrTris, pH 7.5 fol-
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 .  .  .  .  .Fig. 2. Time-course of the uptake of L-alanine A , L-glutamic acid B and D-glucose C in the presence v or absence ‘ of inward
q  .Na gradient. Membrane vesicles 20 ml were incubated with 100 ml of a transport buffer containing 240 mM substrate and either 100
mM NaCl or 100 mM KCl. Each point represents the mean"S.E.M. of 3–6 measurements.
lowed by filtration through a Millipore filter HAWP,
.0.45 mm, 2.5 cm diameter . The filter was then
washed once with 4 ml of ice-cold stop buffer.
2.4. Analytical procedure
The determination of labeled substrates was car-
ried out by liquid scintillation counting. Protein was
w xmeasured by the method of Lowry et al. 11 with
bovine serum albumin as the standard.
3. Results
3.1. Functional integrity of the intestinal brush-border
membrane ˝esicles
Fig. 2 shows the time-course of the uptake of
w3 x w14 x w3 xL- H alanine, D- C glucose, and L- H glutamic
acid in the presence or absence of inward Naq-gradi-
ent. The initial uptake rate of all substrates was
stimulated and an overshoot phenomenon was ob-
served in the presence of a Naq-gradient. The trans-
port activity was comparable to other reports about
w xthe uptake of these substrates 12–14 . These results
reveal a functional integrity of the membrane prepa-
rations.
3.2. Effect of imipramine on the Naq-dependent
transport
Table 1 shows the effect of imipramine on the
initial uptake of substrates in the presence or absence
of a Naq-gradient. Imipramine inhibited the uptake in
the presence of a Naq-gradient with a concentration
dependent manner, whereas the uptake in the absence
of Naq-gradient was not affected. Moreover, the
 .equilibrium 30 min uptake in the presence of a
q  .Na -gradient was also not affected not shown . These
results suggest that the inhibitory effect of imipramine
is exclusive for the Naq-dependent carrier-mediated
component. Therefore, in the subsequent kinetical
analyses, we normalized the uptake values by sub-
tracting the uptake in the absence of Naq-gradient
from the total uptake in the presence of Naq-gradient
in order to precisely evaluate the net effect induced
by imipramine on the Naq-dependent transport com-
ponent.
3.3. Type of the inhibitory effect of imipramine on the
transport of L-glutamic acid
 .Fig. 3 shows a double reciprocal 3A and a
 .Dixon-type 3B plots of the inhibitory effect of
imipramine on the transport of L-glutamic acid with
respect to competition for L-glutamic acid binding
site. The manner of inhibition is in agreement with a
noncompetitive rather than competitive type with a
 .K value of 0.81 mM .I
Then we examined the effect of imipramine on the
transport of L-glutamic acid with respect to the inhibi-
tion of Naq-binding. It has been reported that the
stoichiometry of the Naq-dependent transport of L-
 q . w xglutamic acid is 2:1 Na :L-glutamic acid 15,16 .
We examined the dependency of the transport of
L-glutamic acid on the Naq concentration at 200 mM
L-glutamic acid, and analyzed it using the Hill equa-
tion:
n nq n q˝sVm Na r K q Na 1 . .Na
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Table 1
Effect of imipramine on the uptake of L-alanine, L-glutamic acid, and D-glucose in the presence or absence of a Naq gradient
 .Substrate Imipramine concn. Uptake pmolrmg protein
 .  . q qincubation time mM In the presence of Na gradient In the absence of Na gradient
 .Alanine 15 s 0 365.4"31.8 186.9"13.4
0.25 N.D. 162.7"13.3
)0.5 277.0"16.9 165.9"17.8
)1 231.1"24.0 N.D.
)2 131.3"11.0 N.D.
 .Glutamic acid 30 s 0 230.1"19.1 47.3"10.5
)0.5 174.7"27.3 45.4"10.9
)1 154.9"41.2 46.3"9.9
)2 115.3"43.1 46.4"11.9
 .Glucose 15 s 0 228.2"28.1 63.9"13.0
0.125 N.D. 57.6"17.8
0.25 N.D. 67.9"8.0
)0.5 134.2"24.2 60.8"13.4
0.75 N.D. 44.1"20.2
)1 95.8"29.4 N.D.
)2 69.1"19.9 N.D.
 .Membrane vesicles 20 mM were incubated with 100 mM of a transport buffer containing 240 mM substrate, various concentrations of
imipramine and either 100 mM NaCl or 100 mM KCl. Each value represents the mean"S.D. of 3-17 measurements.
) p-0.001 significantly different from the value without imipramine. N.D.: not determined.
Fig. 3. Analysis of the inhibitory effect of imipramine on L-glutamic acid uptake with respect to the inhibition of L-glutamic acid binding
 .to the carrier. Membrane vesicles 20 ml were incubated with 100 ml of transport buffer containing 100 mM NaCl and various
concentrations of L-glutamic acid and imipramine. Each point represents the mean value of 3–6 measurements. A; Final concentrations
 .  .  .  .  .  .  .  .mM of imipramine were 0 ‘ , 0.5 ^ , 1 I and 2 v . B; Final concentrations mM of L-glutamic acid were 50 ‘ , 75 ^ , 100
 .  .  .  .I , 200 v and 500 ’ . Inset: replot of the slopes of Dixon-type plot
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Fig. 4. Analysis of the inhibitory effect of imipramine on L-glutamic acid uptake with respect to the inhibition of Naq binding to the
 .carrier. Membrane vesicles 20 ml were incubated with 100 ml of a transport buffer containing 240 mM L-glutamic acid and various
q  .concentrations of Na and imipramine. Each point represents the mean value of three measurements. A: Final concentrations mM of
 .  .  .  .  .imipramine were 0 ‘ , 0.5 ^ , 1 I and 2 v . Inset: replot of the slopes of the double reciprocal plot ; B: Final concentrations
 . q  .  .  .  .  .  .mM of Na were 20 ‘ , 27 ^ , 40 I , 55 v and 83 ’ . Inset: replot of the slopes of Dixon-type plot
where n, and K are the Hill and affinity coeffi-Na
cients of the Naq-binding to the carrier, respectively.
Fitting of the uptake data of L-glutamic acid in the
presence of various concentrations of Naq using Eq.
 .1 yields the following values: ns2.18, K s50Na
 .  .mM , and Vms184 pmolr mg proteinr30 s .
Because the Hill coefficient is 2.18, it is suggested
that this carrier system has at least two sites for
Naq-binding.
For the sake of simplicity, we referred to the report
w xof Prezioso and Scalea 16 and analyzed the data
 .depending on the following supposition: 1 L-
glutamic acid binding to the carrier moiety is permis-
sible only after both of the Naq-binding sites are
 . qoccupied; 2 Na does not bind to the carrier moiety
 .which is already occupied by imipramine; 3 the
number of the carrier moieties that occupied only one
Naq-site by Naq or imipramine are negligible be-
cause of the cooperativity. Therefore, the transport
kinetics of L-glutamic acid can be resembled by the
following equation:
2q˝sVm Glu Na r K PK PK Na1 Na2 Glu
2 2q qqK Na q Glu Na 2 .5Glu
Then, the equation of the relation between the
transport rate and Naq concentration and imipramine
concentration is:
2q˝sVm Glu Na r K PK PK 1 Na1 Na2 Glu
2 2qq I rK PK qK Na q Glu/I1 I 2 Glu
=
2qNa 3 .5
where K , K , K are the affinity constants ofNa1 Na2 Glu
the binding of Naq to the first and the second
binding sites of carrier, and the affinity constant of
the binding of L-glutamic acid, respectively. K andI1
K are the affinity constants of imipramine to theI2
w xfirst and the second binding sites of the carrier. Glu
w xand I are the concentrations of L-glutamic acid and
 .Imipramine, respectively. From Eq. 3 , the recipro-
w x2cal of ˝ is proportional to I and the reciprocal of
w qx2 w qx2Na . Fig. 4 shows the plot of 1r˝ vs. 1r Na
w x2and 1r˝ vs. I . As shown in the inset of Fig. 4, the
inhibition of L-glutamic acid transport is competitive
with respect to the binding of Naq. K PK valueI1 I 2
calculated from the x-intercept of the replot of the
w qx2slopes obtained from 1r˝ versus 1r Na is 0.53
 2.mM .
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Fig. 5. Analysis of the inhibitory effect of imipramine on L-alanine uptake with respect to the inhibition of Naq binding to the carrier.
 .Membrane vesicles 20 ml were incubated with 100 ml of a transport buffer containing 240 mM L-alanine and various concentrations of
q  .Na and imipramine. Each point represents the mean value of 3–4 measurements. A: Final concentrations mM of imipramine were 0
 .  .  .  . q  .  .  .  .  . ‘ , 0.25 ^ and 0.5 I . B: Final concentrations mM of Na were 25 ‘ , 40 ^ , 50 I , 60 v and 83 ’ . Inset: replot of
.the slopes of Dixon-type plot
Fig. 6. Analysis of the inhibitory effect of imipramine on D-glucose uptake with respect to the inhibition of Naq binding to the carrier.
 .Membrane vesicles 20 ml were incubated with 100 ml of a transport buffer containing 240 mM D-glucose and various concentrations of
q  .Na and imipramine. Each point represents the mean value of 3–7 measurements. A: Final concentrations mM of imipramine were 0
 .  .  .  . q  .  .  .  .  . ‘ , 0.25 ^ and 0.5 I . B: Final concentrations mM of Na were 25 ‘ , 40 ^ , 50 I , 60 v and 83 ’ . Inset: replot of
.the slopes of Dixon-type plot
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3.4. Type of the inhibitory effect of imipramine on the
transport of L-alanine and D-glucose
Plots of inhibitory effect of imipramine on the
uptake of L-alanine and D-glucose in the presence of
various concentrations of Naq are shown in Figs. 5
and 6, respectively. Double reciprocal plot and Dixon
plot showed that the inhibition of the uptake of both
substrates was due to a competitive or partially com-
petitive inhibition of Naq-binding by imipramine.
Moreover, the replots of the slopes obtained from
Dixon plot indicate that the inhibitory effect exerted
on the D-glucose transport is rather a pure competi-
tive type whereas that exerted on the L-alanine trans-
port is rather a mixed one although the y intercept is
very close to the origin. The K values for L-alanineI
 .and D-glucose transport were 0.26 mM and 0.17
 .mM , respectively.
4. Discussion
This is the first study to analyze the effect of an
organic cation on the transport of L-glutamic acid.
L-Glutamic acid is an acidic amino acid transported
by Naq co-transport system with a stoichiometry of
substrate: Naqs1:2. Therefore, it is interesting to
compare the inhibitory effects with those obtained
with L-alanine, a neutral amino acid, and D-glucose,
which have a stoichiometry value with Naq of 1:1.
On the basis of some assumptions mentioned above
 .  .Section 3.3 , we introduced Eq. 3 which shows the
kinetics of the inhibition when the transport ratio of
substrate and Naq is 1:2, and inhibition is occurred
on Naq-binding sites. We used this equation for the
analysis of mechanism of inhibitory effect by
imipramine on L-glutamic acid transport. As shown
in Fig. 4, imipramine competitively inhibit the bind-
ing of Naq, but it does not compete with L-glutamic
 .acid Fig. 3 . On the other hand, it is possible that
imipramine inhibit the transport of L-glutamic acid by
bind to only one of two Naq-binding sites. However,
when we analyze the uptake data using the equation
under this assumption, linear line was not obtained by
 w x.Dixon type plot 1r˝ vs. I . Therefore, it would be
appropriate that imipramine bind to both two Naq-bi-
nding sites. These results are similar to the results
 .with L-alanine and D-glucose Figs. 4 and 5 , and
suggest that the manner of the inhibitory effect of
imipramine on the Naq-dependent carrier systems is
common for all systems regardless of the stoichiom-
etry or substrates. Although the sequential order of
the inhibitory events for L-glutamic acid transport can
not be elucidated from the results of this study, a
model that imipramine binds to both Naq-binding
sites before the binding of L-glutamic acid can be
w x  .inferred 16 from the graphical fitting using Eq. 3
 .Fig. 4 .
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